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Anxiety disorders are characterized by ongoing and situationally disproportionate 
fear and anxiety, and the associated significant distress and impairment of normal 
functioning (American Psychiatric Association, 2013). These disorders affect 
nearly one third of Americans in their lifetimes, indicating that a massive group of 
people stand to benefit from the development of effective and feasible treatments 
for anxiety symptoms (Valentiner, Fergus, Behar, & Conybeare, 2014). Possibly as 
a result of the rise in use of pharmaceutical treatments, research on exciting 
alternatives such as biofeedback to treat the symptoms of anxiety slowed in the 
early 1990s. However, sufferers generally seem open to the use of complementary 
and alternative therapies for anxiety and depression, especially those that have 
fewer side effects than pharmaceutical treatments (Kessler et al., 2001). 
Fortunately, there has been a resurgence in studying these treatments as researchers 
learn more about the patterns of neural activity and states of physiological 
functioning associated with anxiety disorders. Researchers are investigating the 
general efficacy of biofeedback for anxiety, as well as which types of biofeedback 
may be most effective for which types of symptoms and disorders. For example, 
EEG biofeedback (also referred to as neurotherapy) may be most effective for 
disorders such as generalized anxiety disorder in which conscious experience is a 
crucial component, and HRV (heart rate variability) biofeedback may be most 
effective for disorders such as panic disorder in which the individual experiences 
frequent and intense autonomic arousal (Schoenberg & David, 2014). 
In this paper, I will review the available research on biofeedback treatments 
for anxiety disorders, a project I restrict to those anxiety disorders within the 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 
categorization; I focus on those disorders that have received enough attention in 
the field to draw at least preliminary conclusions (panic disorder, generalized 
anxiety disorder, and similar historical diagnoses). I will consider each popular 
type of biofeedback treatment with respect to specific anxiety disorders when 
possible, and discuss which symptoms the treatments impact and why certain 
treatments may be most effective for certain symptoms or anxiety disorders. I will 
consider what factors contribute to or mitigate the efficacy of biofeedback 
treatments, and I will delve into the limitations of the research that has been 
conducted thus far, such as limited samples and ethical concerns, (Hammond, 
2005; Reiner, 2008). Finally, I will discuss implications of the current findings and 
I will make recommendations for future research to advance the field. It is critical 
that biofeedback research continue to support the development of promising 
alternatives to pharmaceutical treatments, potentially providing opportunities for 
more accessible treatment with fewer side effects. 
 
Theoretical Background 
 
Evolution of the DSM 
One challenge in reviewing this body of literature is that research depends on 
consistent functional definitions of the disorders studied, but the literature spans 
multiple editions of the DSM, which define and categorize anxiety disorders 
differentially over time. The relevant research really began in the late 1970s and 
early 1980s around the advent of the DSM-III, which split anxiety neurosis into 
panic disorder (characterized by periods of intense anxiety or panic/anxiety 
attacks) and generalized anxiety disorder (Barlow et al., 1984). This split was 
supported by evidence that the two types of disorders responded better to different 
types of medication (Klein, 1964; Rickels, 1993). The DSM-III-R redefined 
generalized anxiety disorder from a residual category into a disorder with its own 
specific criteria, with extensive worry at its core (Rice, Blanchard, & Purcell, 
1993). The DSM-IV anxiety category included generalized anxiety disorder, panic 
disorder, agoraphobia without panic disorder, specific phobia, social phobia, 
obsessive-compulsive disorder, post-traumatic stress disorder, and acute stress 
disorder. 
The DSM-5 split these disorders based on response to treatment and possible 
etiologies, and so the anxiety category includes only separation anxiety disorder, 
selective mutism, specific phobia, social anxiety disorder, panic disorder, 
agoraphobia, generalized anxiety disorder, and residual categories (American 
Psychiatric Association, 2013). This review will largely focus on research 
regarding panic disorder and generalized anxiety disorder as these disorders have 
the longest legacy of research and remain central to the field today. The early 
research on biofeedback and anxiety disorders tends to conflate panic disorder and 
generalized anxiety disorders, but I have attempted to tease these results apart 
when possible. There is minimal, if any, research on the effects of biofeedback on 
the majority of the other DSM-5 anxiety disorders. It is likely that this dearth of 
biofeedback research is due to satisfactory existing treatments, such as exposure 
therapy for specific phobias, which is very effective in a short time frame with 
minimal resources (Valentiner et al., 2014).  
 
Panic Disorder and Generalized Anxiety Disorder: Why Biofeedback Might 
Work 
Both panic disorder and generalized anxiety disorder have physiological 
components, which may be targeted with a variety of biofeedback techniques. 
Panic disorder is characterized by panic attacks, which are brief periods of massive 
autonomic arousal including elevated heart rate. Generalized anxiety disorder is 
associated with persistent worry, but this cognitive state is associated with overall 
muscle tension and the physiological consequences of prolonged tension such as 
headaches and muscle soreness (Valentiner et al., 2014). Biofeedback targeting 
these physiological components may be administered alone or in conjunction with 
psychotherapy and/or medication. 
 
Types of Biofeedback 
Strong trends in popular types of biofeedback to study run parallel to the evolution 
of the DSM and the development of new technologies over time. The major 
therapeutic techniques have been EMG, EEG, and HRV feedback training. 
EMG. The first major trend in biofeedback was centered on 
electromyography (EMG) training, which provides feedback—usually auditory 
(click or tone) feedback—reflecting the electrical activity of the muscles, an 
indicator of muscle tension. Much of the early EMG research suggested frontalis 
EMG feedback, in which sensors are placed on the forehead in the hope that this 
location is critical to the muscle tension of anxiety and that it correlates with 
general bodily tension, as a promising direction for developing anxiety treatments 
(Hoffman, 1979). The technique was originally developed to treat tension 
headaches, but Hoffman (1979) hypothesized that it may be a useful treatment for 
the somatic symptoms of anxiety neurosis. This sparked major interest in utilizing 
EMG to treat anxiety for at least the following decade. There are many limitations 
to this technique, which may explain its disappearance from the current literature, 
including mixed experimental results, prohibitive costs, and the development of 
new technologies. 
EEG. Electroencephalography (EEG) feedback, also known as 
neurofeedback or neurotherapy, was originally developed as a relaxation technique 
related to meditation (Kamiya, 1969; Michael, Krishnaswamy, & Mohamed, 
2005). EEG involves measuring the general patterns of activity of the brain and 
can be used as a diagnostic assistant (usually via quantitative EEG or qEEG) or 
feedback tool (Hammond, 2010, 2011). Feedback can be auditory or visual, even 
in the form of a computer game. In this way, participants learn to regulate specific 
frequencies of cortical activity. As a feedback therapy, it has been used in many 
different psychological and medical disorders, including attention deficit-
hyperactivity disorder, autism spectrum disorder, and substance use disorder 
(Myers & Young, 2012). It has also been used to treat the more cognitive 
components of anxiety disorders and may be more effective in those disorders in 
which the cognitive experience is central, such as generalized anxiety disorder 
(Schoenberg & David, 2014). Most practitioners claim there is little to no short- or 
long-term risk involved in neurofeedback, but some caution that to minimize risk it 
is critical to individualize treatment using qEEG because of the heterogeneity of 
EEG presentations of various disorders and comorbidities (Hammond, 2010; 
Walker, 2010). 
HRV. Heart rate variability (HRV) was initially applied to panic disorder 
and related diagnoses because tachycardia (fast heart rate) and related autonomic 
activities are central to the definition of a panic attack (American Psychiatric 
Association, 2013). HRV is related to earlier measures of autonomic activity, such 
as the simple heart rate or blood pressure reading, but it allows for more sensitive 
interpretations that take into account contributions of both the sympathetic nervous 
system (SNS; activation, generally) and parasympathetic nervous system (PNS; 
inhibition, generally, Friedman & Thayer, 1998a, 1998b). To a lesser extent, HRV 
has also been studied in the context of generalized anxiety disorder, especially 
during periods of worry (Thayer, Friedman, & Borkovec, 1996). 
Three major HRV components are typically analyzed in this body of 
research. The first is the quick, high frequency component (HF), which is related to 
respiration and is used as a vagal tone index. The mid-frequency component (MF) 
is associated with blood pressure regulation and is influenced by both the SNS and 
the PNS to varying degrees. Finally, the slow, low frequency component (LF) is 
influenced by temperature, vasomotor, hormonal, and metabolic regulation, and 
may be primarily regulated by the SNS (Friedman, 2007). 
There is a large body of work arguing for various theories explaining the 
autonomic dysregulation in anxiety, but an in-depth analysis of this work is largely 
beyond the scope of this review. In brief, polyvagal theory and neurovisceral 
theory can be combined into an autonomic flexibility-neurovisceral integration 
model (Porges, 1992; Thayer & Lane, 2000). In this model, anxiety is associated 
with impaired homeodynamics (reactive flexibility critical to normal functioning) 
of the autonomic nervous system, as mediated by the central autonomic network 
(CAN) and a lack of normal inhibition of excessive emotional response at multiple 
levels (Friedman, 2007). 
Two common forms of HRV biofeedback are resonant frequency HRV 
biofeedback, which teaches participants to optimize their breathing rate to the 
cardiovascular system, and HeartMath HRV biofeedback, which incorporates an 
affective component to create a sort of physiological-cognitive-behavioral hybrid 
treatment (Hassett et al., 2007; Henriques, Keffer, Abrahamson, & Horst, 2011; 
Muench, 2008). 
 
Biofeedback Evidence 
 
EMG 
EMG feedback research has been conducted with a diverse set of clinical and 
nonclinical populations, including those with DSM-II anxiety neurosis (Canter, 
Kondo, & Knott, 1975; Hoffman, 1979; Lavellée, Lamontagne, Annable, & 
Fontaine, 1982), psychiatric patients with chronic anxiety (Leboeuf & Lodge, 
1980; Rupert, Dobbins, & Mathew, 1981; Scandrett, Bean, Breeden, & Powell, 
1986), and individuals with subclinical but high anxiety (Lustman & Sowa, 1983; 
Reed & Saslow, 1980). Barlow et al. (1984) performed a critical comparison of the 
effects of EMG feedback as a component of therapy for individuals with DSM-III 
panic disorder or generalized anxiety disorder, but results were inconclusive and 
forms of therapy were gaining traction around this time. By the end of the 1980s, 
the field had progressed past EMG biofeedback. Research on the effects of EMG 
feedback is shown in Table 1. 
Early evidence of EMG feedback was quite promising for anxious patients. 
In a pool of 28 anxious neurotics, half of which presented with panic attacks and 
half of which did not, EMG feedback and Jacobsenian Progressive Relaxation was 
associated with significant reduction in muscle tension for both groups, but the 
EMG-treated patients showed a greater and more rapid reduction. Further, a 
significantly greater proportion of the EMG group reported improvements in 
anxiety symptoms, a change which was corroborated by their primary therapists. 
Ultimately, the patients without panic attacks who received feedback training 
demonstrated reduced muscle tension to a lesser degree, possibly due to a lower 
baseline (Canter et al., 1975). Hoffman (1979) considered an extremely small 
sample of 4 adult patients with tension headache and 5 adult patients with anxiety 
neurosis. Overall, he found that EMG feedback was associated with reduced 
muscle tension in all patients, but only one of the patients with anxiety neurosis 
was denoted as “much improved” in terms of anxiety symptoms by clinical 
assessment – the others were either “unimproved” or “worse” following EMG 
treatment. 
In these studies, EMG feedback training was seemingly effective in lowering 
frontalis muscle tension, but this was associated to varying degrees with the central 
symptoms of anxiety. When considering who may respond to such treatment, 
Lavellée et al. (1982) demonstrated that only 25% of participants reported 
decreased anxiety as a result of successful EMG training and that these 
“responders” were more extraverted and less depressed. Further, individuals who 
respond to such treatment may be more susceptible to hypnosis, implying a critical 
cognitive component to EMG biofeedback (Rupert et al., 1981). Hoffman (1979) 
had posited that EMG feedback may not be an appropriate treatment for anxiety, 
but others attempted to dig deeper. EMG feedback seemed to improve some of the 
somatic symptoms associated with anxiety such as blood pressure in subclinical 
populations (Lustman & Sowa, 1983), as well as reducing heart rate, frequency of 
anxiety attacks, sleeping difficulties, and locomotor agitation in clinical 
populations (Barlow et al., 1984; Scandrett et al., 1986). It was unclear, however, 
to what degree this treatment exceeded the efficacy of more traditional treatments 
such as pharmaceuticals and relaxation instructions. In a sample of 40 adult 
outpatients suffering from chronic anxiety (likely conflating panic disorder and 
generalized anxiety disorder), EMG feedback resulted in reduction in frontalis 
muscle tension as well as anxiety symptoms and this effect was maintained at a 3 
month (but not a 6 month) follow-up, whereas patients taking diazepam showed an 
initial reduction in tension, but this was not maintained at follow-up and was 
associated with negative side effects (Lavallée, Lamontagne, Pinard, Annable, & 
Tétreault, 1977). Some studies showed that both EMG feedback and relaxation 
instructions resulted in reduced trait anxiety in chronic anxiety patients (Rupert et 
al., 1981), even when panic disorder and generalized anxiety disorder were 
considered separately (Barlow et al., 1984). EMG feedback and relaxation also 
reduced test anxiety and general anxiety in highly anxious undergraduate students 
(Reed & Saslow, 1980), but another study showed that neither EMG feedback nor 
progressive relaxation had a significant effect on reducing anxiety in chronically 
anxious patients (Leboeuf & Lodge, 1980). 
The theoretical foundation of EMG feedback seems especially sound for 
chronic anxiety and generalized anxiety disorder, as it could target the somatic 
manifestations of worry. However, the evidence is mixed at best regarding the 
relative efficacy of EMG biofeedback. In addition, this body of research is rife 
with experimental design limitations, including small sample sizes, lack of control 
groups, and inconsistencies in the EMG feedback itself (length of treatment, 
combination with other forms of therapy). On the whole, the research tended to 
exclude anxious participants who presented with potentially confounding 
comorbidities such as phobias, psychosis, depression, and obsessions, but many 
studies did not isolate anxious individuals who presented with persistent panic 
attacks, and when they did, they suffered from other design limitations such as 
small sample size. Anxiety is understood to be a complex disorder, so it is likely 
that biofeedback in conjunction with traditional cognitive-behavioral therapy 
would have a different effect than biofeedback alone, but in this research, EMG 
biofeedback was generally assessed as an isolated treatment, and if combined, it 
was usually combined with relaxation techniques. Perhaps as a result of these 
limitations as well as the financial means and technological expertise required to 
utilize EMG feedback (Reed & Saslow, 1980), this particular realm of biofeedback 
research has since fallen out of fashion. 
 
Table 1 
Electromyography (EMG) Biofeedback (BF) 
 
References Sample Design Results 
Barlow et al. 
(1984) 
GAD (n=9) and 
PD (n=11) 
Treatment (fEMG, 
progressive relaxation, + 
CBT over 14 weeks) vs. no 
treatment 
Improvement in muscle 
tension and anxiety 
symptoms, both groups 
Canter et al. 
(1975) 
Anxiety neurosis 
(n=28) 
EMG vs. progressive 
relaxation with no 
feedback 
EMG and PMR à 
reduced muscle tension; 
EMG à reduced anxiety 
Hoffman (1979) Anxiety neurosis 
(n=9) 
EMG, no control Improvement in one 
anxiety patient 
Lavallee et al. 
(1977) 
Chronic anxiety 
(n=40) 
EMG and Diazepam, EMG 
and placebo, EMG w/o 
feedback (control), EMG 
control and placebo 
All groups reduced 
anxiety, Diazepam alone 
least effective; EMG 
improvements 
maintained 3 months 
Lavallee et al. 
(1982) 
Chronic anxiety 
(n=40) 
fEMG, no control Only 25% improved; 
Responders initially less 
depressed and more 
extraverted 
Leboeuf and 
Lodge (1980) 
Chronic anxiety 
(n=26) 
fEMG vs. progressive 
relaxation 
Both improved anxiety 
and muscle relaxation 
Lustman and 
Sowa (1983) 
Anxiety and stress 
(n=24) 
EMG BF vs. stress 
inoculation vs. no 
treatment 
Both treatments lowered 
blood pressure, reduced 
anxiety 
Reed and 
Saslow (1980) 
Test anxiety and 
general anxiety 
(n=27) 
EMG vs. relaxation 
training vs. no treatment 
Both treatment groups 
improved in test and 
general anxiety 
Rupert et al.  
(1981) 
Chronic anxiety 
(n=20) 
EMG vs. relaxation vs. 
combination vs. no 
treatment 
EMG improved trait 
anxiety 
Scandrett et al. 
(1986) 
Anxiety disorder 
(n=88) 
fEMG vs. PMR vs. wait-
list control 
No sig. changes 
 
 
EEG 
Though EEG technology has been utilized in human psychology since 1924 (Haas, 
2003), EEG feedback training has a relatively short history. Research has 
burgeoned in the last decade or so, with approximately 250 studies utilizing 
neurofeedback from 2008-2012 with promising but not definitive results (Myers & 
Young, 2012). This line of research corresponds to the NIMH Research Domain 
Criteria, encouraging investigation of the biological underpinnings of 
psychological processes and dysfunctions that result in pathology (Insel et al., 
2010). While EEG is a relatively cheap research technique (compared with 
massive equipment such as fMRI), its cost has been rather prohibitive for use in 
therapy or counseling without evidence significant clinical results. The estimated 
cost is $10,000, including extensive training and equipment (Myers & Young, 
2012). To examine and establish the effectiveness of EEG training in reducing 
anxiety, many researchers have focused on high trait-anxiety in non-clinical 
populations as this is a risk factor for developing anxiety disorders, but working 
with this population is more ethically acceptable as the research is not impeding 
patient access to treatment (Hardt & Kamiya, 1978; Logemann, Lansbergen, Van 
Os, Böcker, & Kenemans, 2010; Plotkin & Rice, 1981; Vendemia & Rodriguez, 
2010; Wang et al., 2013). A survey of research on the effects of EEG biofeedback 
is shown in Table 2. 
When considering clinical populations, researchers have looked at either 
diverse diagnoses accompanied by varying degrees of anxiety (Bhat, 2010; 
Michael et al., 2005; Saldanha, Chaudhury, Pawar, Ryali, & Srivastava, 2007) or 
generalized anxiety disorder (Rice et al., 1993). It is likely that researchers rarely 
considered panic disorder because the theoretical foundation of EEG feedback 
training is that it targets the cognitive components of a disorder. This is well-suited 
to generalized anxiety disorder and subclinical high trait-anxiety because this type 
of anxiety is characterized by cognitive worry and attentional bias, whereas panic 
disorder is less associated with such cognitions and is more associated with 
misattribution of and overreaction to physical experience (Chen et al., 2013). 
In general, this research has focused on EEG alpha wave enhancement – a 
low frequency band of brain activity associated with a relaxed awake state, and 
associated with meditation and pleasant feelings through research in the 1960s 
(Kamiya, 1969). Higher frequency beta waves are associated with cognitive 
processing, and the lowest frequency theta waves are associated with sleep (Myers 
& Young, 2012). Hardt and Kamiya (1978) were among the first to demonstrate 
that when applied to a group of high trait-anxiety individuals, EEG alpha 
enhancement effectively reduces state anxiety whereas alpha suppression increases 
state anxiety. No effect was seen for low trait-anxiety individuals, which may 
account for the inconclusive results in previous studies. This research set a 
precedent for considering individual differences to understand the impact of EEG 
feedback training. In another seminal study, Plotkin and Rice (1981) exposed how 
the placebo effect influences EEG feedback results in a nonclinical sample, albeit 
with an extremely small sample size (n=10). Both EEG alpha enhancement and 
EEG alpha suppression feedback produced a significant reduction in trait anxiety 
when participant expectation was manipulated to induce perceived success. In a 
follow-up to this study, Rice et al. (1993) demonstrated that perceived success  
plays a role in treatment, but does not account for the entire effect of EEG 
feedback. In adults meeting the DSM-III-R criteria for GAD or high subclinical 
levels of generalized anxiety, EEG alpha enhancement resulted in significant 
reduction in heart rate responsivity and EEG alpha suppression resulted in the 
opposite pattern. This study also demonstrated that fEMG and EEG alpha training 
all reduce trait anxiety and anxiety symptoms, implying that GAD may be treatable 
with a variety of biofeedback techniques (Rice et al., 1993). 
In current EEG feedback research with clinical populations, it seems that 
studies have mostly, if not entirely, been conducted outside of the United States, 
potentially due to stringent ethical guidelines. Currently, there are generally 
effective treatments for anxiety, and EEG may be associated with risk, but some 
argue that it is unnecessary to conduct research on a potentially harmful new 
treatment. Perhaps for similar reasons, the international literature tends to consider 
the anxiety levels of psychiatric and medical patients with diverse diagnoses. 
Michael et al. (2005) considered cardiac patients at a Malaysian hospital with three 
different levels of anxiety: normal, mild/moderate, and severe. Many patients who 
completed initial screenings in the study dropped out, but that population agreed to 
participate in the follow-up testing and were considered a pseudo-control group. 
Overall, the participants demonstrated reduced anxiety symptoms over controls 
after EEG beta and sensory motor rhythms (another type of EEG wave) feedback 
training, but little change in actual EEG activity, implying a placebo effect 
(Michael et al., 2005). 
Interestingly, two Indian studies investigated the differential effects of 
neurofeedback, pharmaceutical treatment, and a combination of the two in military 
veterans. Bhat (2010) compared the efficacy of EEG alpha enhancement relative to 
anxiolytics alone in a sample of 100 veterans with mild to severe anxiety and 
found that anxiety symptoms improved for both groups and that EEG feedback 
was particularly effective for generalized anxiety disorder and for females 
(possibly due to a greater motivational “buy-in” or compliance). In a similar 
population of individuals with neurotic and/or psychosomatic disorders, Saldanha 
et al. (2007) utilized multiple combined methods of biofeedback, psychoactive 
medication, and a combination of biofeedback and medication. The combination of 
biofeedback and medication seemed to be most effective in reducing anxiety 
symptoms, and as the medication was gradually withdrawn and effects maintained 
over the course of treatment, this strategy was the most promising in certain cases 
(Saldanha et al., 2007). In a general sample of 40 Canadian aboriginal adults, a 
population in which psychopathology tends to be overrepresented, Hardt (2013) 
found that EEG alpha enhancement resulted in significant decreases in anxiety 
symptoms and negative affect as measured in four separate and validated 
personality tests. While these results seem promising, the general lack of controlled 
research regarding EEG feedback in treating anxiety is a major limitation in this 
field. 
One of the newest directions of EEG feedback research is focused on 
training to reduce or normalize attentional biases that may be pathological in 
anxiety disorders in particular. The attentional bias theory states that high trait-
anxious individuals tend to experience an exaggerated interpretation of threat-
related stimuli (Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, & van 
IJzendoorn, 2007; Eysenck & Derakshan, 1997). While Logemann et al. (2010) 
failed to show an effect of EEG feedback on attention in non-clinical inattentive 
and impulsive undergrads, this may have been due to design limitations such as a 
small sample size and ceasing the study early, which was due to ethical 
considerations and the lack of progress mid-way through the planned timeline. 
Vendemia and Rodriguez (2010) discovered differential EEG patterns correlated to 
coping style (high-anxious vs. low-anxious vs. repressors), particularly that the 
high-anxious group showed more overall activity throughout alpha and beta bands 
in response to the emotional Stroop task. Taking this research one step further, 
Wang et al. (2013) considered EEG feedback and attentional biases in two groups 
of Chinese female undergraduates, a high trait-anxiety group (HTA) and a 
nonanxious group (NA). First, in an emotional Stroop task, the HTA group 
demonstrated a significant attentional bias toward negative words manifested in a 
slower reaction time, associated with a longer P300 latency (measured with event-
related potential [ERP] recording). In a second experiment, EEG alpha 
enhancement was compared with sham-biofeedback in the HTA group. Critically, 
EEG feedback significantly reduced trait anxiety relative to sham-biofeedback, 
alpha amplitudes were significantly enhanced, and P300 latencies for negative 
words were shortened (Wang et al., 2013). This is strong evidence that EEG alpha 
enhancement can reduce the negative attentional biases commonly found in 
anxiety patients, and that the mechanism by which neurofeedback affects anxiety 
may work at the level of attentional bias. This promising result is consistent with 
the theory that neurofeedback is dependent on cognitive mechanisms and affects 
the cognitive aspect of psychopathology, and may have major implications for the 
development of a neurofeedback treatment for anxiety targeting attentional bias. 
 
 
 
 
Table 2 
Electroencephalography (EEG) Biofeedback (BF) 
 
References Sample Design Results 
Bhat (2010) Indian veterans, mild 
to severe anxiety 
(n=100) 
EEG alpha 
enhancement vs. 
anxiolytics 
Anxiety symptoms 
improved in both 
groups; EEG-BF 
better for GAD and 
females 
Chen et al. (2013) GAD (n=42), PD 
(n=34), and controls 
(n=46) 
GAD vs. PD vs. 
Controls in emotional 
Stroop task with GD-
related and PD-related 
words 
GAD and PD slower 
to respond; 
Differential pattern of 
attentional bias, no 
evidence to suggest 
unique PD bias 
Hardt and Kamiya 
(1978) 
Non-clinical male 
undergrads, low vs. 
high anxiety (n=16) 
EEG alpha 
enhancement vs. EEG 
alpha suppression, no 
control 
High anxiety group – 
alpha enhancement 
reduced state anxiety, 
alpha suppression 
increased state anxiety 
Hardt (2013) Canadian aboriginal 
adults (n=40) 
EEG alpha 
enhancement, no 
control; Personality 
measures 
Statistically 
significant decreases 
in anxiety and 
negative affect with 4 
personality tests 
Logemann et al. 
(2010) 
Non-clinical high 
impulsivity/inattention 
(n=27) 
EEG vs. sham 
feedback 
No effect, ended early 
due to ethical 
guidelines 
Michael et al. (2005) Malaysian cardiac 
patients, normal to 
severe anxiety (n=38); 
many dropped out 
EEG beta/sensory 
motor rhythms 
training vs. dropouts 
(pseudocontrol) 
Reduced anxiety vs. 
dropouts; Minimal 
EEG changes, implies 
placebo effect 
Plotkin and Rice 
(1981) 
Non-clinical male 
undergrads, high trait 
anxiety (n=10); many 
dropped out 
EEG alpha 
enhancement vs. 
suppression; 
expectation of success 
consistent 
Both groups – 
significant reduction 
in trait anxiety; 
perceived success 
most important 
Rice et al. (1993) GAD or high 
subclinical anxiety 
(n=45) 
fEMG vs. EEG alpha 
enhancement vs. EEG 
alpha suppression vs. 
pseudomeditation 
control 
All treatments à sig. 
reduction in trait 
anxiety and 
symptoms; only EEG 
alpha increase à 
reduction in HR 
reactivity 
Saldanha et al. (2007) Indian, neurotic and 
psychosomatic 
disorders (n=78) 
Psychoactive drugs 
vs. Biofeedback 
(multiple method, 
including EEG) vs. 
combination  
All groups – reduced 
anxiety symptoms; 
Combination worked 
best, pharmaceuticals 
gradually withdrawn 
Vendemia and 
Rodriguez (2010) 
Non-clinical female 
undergrads, 
repressive, low-
anxious, and high-
anxious coping styles 
(n=49) 
Correlation – EEG 
differences related to 
coping styles in 
emotional Stroop task 
High-anxious 
participants – more 
alpha and beta power 
than low-anxious; 
More attentional bias 
to negative stimuli 
Wang et al. (2013) Chinese non-clinical 
female undergrads, 
high trait-anxiety 
(HTA) and 
nonanxious (n=45) 
EEG alpha 
enhancement vs. sham 
biofeedback in 
emotional Stroop task 
HTA attentional bias 
confirmed, associated 
with longer P300 
latency; Feedback à 
reduced attentional 
bias, anxiety scores, 
and P300 latency 
 
HRV 
As mentioned above, the use of heart rate variability (HRV) feedback for anxiety 
disorders is rooted in complex theory regarding the typical functioning of the 
autonomic nervous system and how it becomes dysfunctional. Generally, the 
models predict that anxiety is associated with a reduced range of HRV and a low 
vagal tone (Friedman, 2007). Low vagal tone is also associated with low 
responsivity to the environment as well as anxiety and antisocial behavior in 
adolescents (Beauchaine, 2001; Mezzacappa et al., 1997). Research investigating 
the effect of HRV biofeedback is shown in Table 3. 
HRV biomarkers. Evidence suggests that panic disorder is associated with 
a low vagal tone and high SNS cardiac control, which fits with the diagnostic 
picture that individuals with panic disorder have less ability to inhibit the fight-or-
flight interaction which leads to a panic attack (Valentiner et al., 2014). HRV has 
also been used to differentiate the autonomic profiles of individuals with panic 
disorder from individuals with blood phobia and nonanxious controls – 
“panickers” presented with the highest heart rate and the lowest heart rate 
variability, whereas blood phobics’ HRV was relatively more vagally mediated. 
This particular study utilized a stress task and a fear task to produce autonomic 
reactions (Friedman & Thayer, 1998a). 
There is some evidence to suggest that HRV markers can also differentiate 
anxiety disorders without panic. In a seminal study by Thayer et al. (1996), 
individuals with generalized anxiety disorder presented with lower vagal activity 
(shorter cardiac interbeat intervals [IBIs] and lower HF spectral power) than 
controls at rest. When individuals with GAD were compared with controls in a 
laboratory-induced worry task, both groups demonstrated lower vagal activity, 
implying that this effect may be representative of the physiological correlate of 
persistent worry associated with anxiety (Thayer et al., 1996). In a study by 
Alvares et al. (2013), social anxiety disorder was found to be associated with 
reduced HRV compared to controls with a relatively large sample size (n=106). 
These results imply that low resting HRV may be a useful biomarker for 
identifying individuals with low approach-related motivation and a potentially 
overactive behavioral inhibition system (Alvares et al., 2013). 
HRV biofeedback. Despite the significant body of evidence to support the 
role of HRV in pathological anxiety, very little research examining HRV 
biofeedback with anxious populations exists. There is some preliminary HRV 
biofeedback research with medical populations (e.g. cardiac diseases), and some 
with clinically anxious populations, but most anxiety-related HRV biofeedback 
training has been conducted with nonclinical populations (Wheat & Larkin, 2010). 
In terms of the resonant frequency HRV biofeedback, the StressEraser 
device is popularly used to teach participants to breathe at the optimal rate (5-6 
breaths per minute) in the face of a stressor (Muench, 2008; Prinsloo, Derman, 
Lambert, & Rauch, 2013; Reiner, 2008; Sherlin, Gevirtz, Wyckoff, & Muench, 
2009). These results are difficult to tease apart because of the small sample sizes 
and general financial support from the company producing the device, which is 
motivated to support research that promotes device sales. However, the device 
seems to show some promise, and a small independent pilot has shown that 
breathing at a rate of 4-6 breaths per minute may increase HRV (Song & Lehrer, 
2003). As a researcher for the StressEraser company, Reiner (2008) demonstrated 
that the StressEraser generally decreases perceived stress and anxiety in a group of 
participants with anxiety disorders. Decrements in anxiety related to degree of 
compliance in the use of the device at home in conjunction with psychotherapy 
(Reiner, 2008). In early independent research with the device, Sherlin et al. (2009) 
demonstrated that in only one short session of biofeedback, non-clinical 
participants with perceived stress demonstrated a decrease in heart rate over 
controls who did not experience the biofeedback. However, while both groups 
experienced a reduction in perceived stress, the decrease in the biofeedback group 
was slightly stronger (Sherlin et al., 2009). In a follow-up study, Prinsloo et al. 
(2013) further demonstrated that a short intervention with the StressEraser in a 
small sample of male adults with work-related stress reduced state anxiety and 
increased mindfulness, energized positive feelings, and basic relaxation over a 
control device. Overall, the StressEraser seems to be a promising device, but larger 
independent and controlled studies must be conducted to determine the validity of 
effects observed. It is likely that the optimal use of this device is in conjunction 
with psychotherapy to address the cognitive components of anxiety. 
HRV biofeedback has also been investigated in the context of non-clinical 
performance anxiety. A well-designed and controlled study by Wells, Outhred, 
Heathers, Quintana, and Kemp (2012) induced performance anxiety in adult 
musicians and compared the effects of a slow breathing intervention, a slow 
breathing with biofeedback intervention, and a no-intervention control. Groups 
who received either intervention appeared to control physiological arousal, but 
there was no significantly different effect on arousal or self-reported anxiety. 
However, individuals with baseline higher anxiety in the interventions did report 
lower levels of state anxiety when compared with control (Wells et al., 2012). 
These results imply that general relaxation techniques may be sufficient to reduce 
autonomic arousal, but this should not be generalized to clinical anxiety or even 
high trait-anxiety individuals, who may benefit further from biofeedback as there is 
more room for improvement. Gruzelier, Thompson, Redding, Brandt, and Steffert 
(2013) compared EEG alpha/theta biofeedback and HRV Freeze-Framer 
biofeedback along with two controls to investigate the impact of these 
interventions on state anxiety and creativity in dance students. Freeze-Framer 
biofeedback plots the heart rate curve on a screen, and provides visual feedback to 
encourage optimal breathing. Only the HRV biofeedback reduced self-reported 
anxiety among the dancers, and HRV was increased through training (Gruzelier et 
al., 2013). Utilizing HRV Freeze-Framer biofeedback with the addition of a 
cognitive affect-shifting component, Henriques, Keffer, Abrahamson, and Horst 
(2011) were able to detect decreases in anxiety, but this was not associated with an 
increase in “psychophysiological coherence.” HeartMath LLC produces Freeze-
Framer, and while coherence is the goal in HeartMath terminology, it may not truly 
capture the effect of this HRV biofeedback. Perhaps if Henriques et al. had access 
to actual HRV measures, a similar effect to that in Gruzelier et al. (2013) would 
have been observed and a reduction in anxiety would have been correlated with an 
increase in HRV. 
Related biofeedback. There has also been research utilizing biofeedback 
with components of HRV such as heart rate and breathing. These studies generally 
do not refer to HRV explicitly, but may have important implications for HRV 
feedback research. 
Heart rate. Heart rate is clearly an important part of HRV, but it is not often 
targeted for HRV biofeedback in favor of slow breathing training. However, heart 
rate may be an important avenue of investigation of biofeedback for anxiety 
disorders. Rupert and Schroeder (1983) posited that if anxious veterans could learn 
to control their heart rates, they might be able to reduce their anxiety levels. Those 
in the heart rate biofeedback group as opposed to the controls were able to non-
significantly reduce anxiety levels, a trend which was correlated with a reduction 
in heart rate (Rupert & Schroeder, 1983). While this was a clinical group, 
individual diagnoses were not analyzed, and it is likely that many of these 
individuals presented with post-traumatic stress disorder, as they were a veteran 
population. 
Thirty years later, utilizing heart rate feedback as an intervention has 
regained interest in the field. Houser et al. (2013) demonstrated in a rural United 
States population of clinically anxious adults that utilizing a heart rate monitor can 
improve state anxiety and self-efficacy. This is a critical pilot study which justifies 
further research on heart rate biofeedback because it is extremely cost effective, 
and may be ideal for populations that are less able to travel to psychotherapy and 
would benefit from a self-directed intervention (Houser et al., 2013). Again, 
however, the study did not differentially analyze individual diagnoses, so it is 
unclear which anxiety disorders for which this treatment may be optimal. In a non-
clinical population, Peira, Fredrickson, and Pourtois (2013) demonstrated that heart 
rate biofeedback could temper an individual’s physiological reactivity in response 
to negative valence images, regardless of individual differences in baseline anxiety 
level or cognitive self-regulation methods. This biofeedback technique may be a 
helpful addition to cognitive approaches to reduce the attentional bias to negative 
stimuli seen in anxious individuals (Peira, Fredrikson, & Pourtois, 2013). In a 
critical follow-up study, Peira, Pourtois, and Fredrickson (2013) investigated 
whether heart rate regulation learned in biofeedback training can transfer to other 
situations without the biofeedback support. Non-clinical participants responded 
well to heart rate biofeedback – they were able to decrease heart rate in training – 
and maintained regulatory improvements in response to negative valence images  –  
decreased heart rate reactivity after training compared with pre-training assessment 
(Peira, Pourtois, & Fredrikson, 2013). This research should be extended to clinical 
populations to assess efficacy and additional research should consider the 
mechanism of this type of intervention effect. 
Breathing. Finally, select research on breathing training and respiratory 
biofeedback may be related to HRV biofeedback (which focuses on respiration), 
although these studies do not discuss HRV explicitly. These studies tend to focus 
on panic disorder (PD) because panic attacks may be produced and maintained by 
reduced carbon dioxide in the blood as a result of hyperventilation. In a small 
sample of 4 individuals with panic disorder, Meuret, Wilhelm, and Roth (2001) 
utilized a respiratory biofeedback device to increase carbon dioxide and reduce 
respiratory rate with breathing exercises. Though this study is not controlled, and 
respiratory biofeedback is confounded with respiratory training, patients tended to 
exhibit reduced panic symptoms and increased blood carbon dioxide after 
intervention (Meuret et al., 2001). Wolburg, Roth, and Kim (2011) provided new 
evidence to support the use of breathing training to lower blood carbon dioxide, as 
participants with anxiety disorders were able to effectively lower or elevate blood 
carbon dioxide in response to a tailored treatment. This study found that PD may 
have specific respiratory abnormalities as previously observed, but results failed to 
confirm that individuals with PD have greater reactivity and slower recovery from 
hypo- or hyperventilation (Wollburg et al., 2011). Thus, research on respiratory 
biofeedback for anxiety, in particular panic disorder, has resulted in mixed 
evidence at best. 
 
Table 3  
Heart Rate Variability (HRV) and related biofeedback (BF) 
 
References Sample Design Results 
Gruzelier et al. 
(2013) 
Non-clinical dance 
students (n=64) 
EEG BF alpha/theta vs. 
HRV BF vs. Choreology 
(dance) class vs. no-
training control 
No impact on dance 
performance; HRV 
BF à reduced anxiety 
Henriques et al. 
(2011) 
Non-clinical 
undergrads, high 
anxiety, interested in 
biofeedback (n=9, 
n=35) 
a) Study 1 – computer-
based HRV, no control 
b) Study 2 – computer-
based HRV, delayed 
treatment control 
Overall decreases in 
anxiety, no sig. 
change to mood, 
general well-being, or 
coherence scores  
Houser et al. 
(2013) 
Anxiety disorder, rural 
U.S. (n=53) 
Heart rate monitor 
feedback (HRM) vs. 
control  
HRM group improved 
sig. more in state 
anxiety and self-
efficacy than control 
Meuret et al. 
(2001) 
Panic disorder (n=4) Respiratory biofeedback, 
initial results so no control 
Blood carbon dioxide 
increased during 
therapy and was 
maintained; Reduced 
panic symptoms 
Peira et al. 
(2013a) 
Non-clinical 
undergrads (n=23) 
True heart rate (HR) BF 
(screen color changes) vs. 
false HR BF; HR 
regulation task vs. HR 
monitoring task; Viewing 
images of differential 
valence 
In regulation task, true 
and false HR BF à 
improved regulation 
in response to neutral 
images; ONLY true 
HR BF à improved 
regulation in response 
to negative images 
Peira et al. 
(2013b) 
Non-clinical 
undergrads (n=20) 
Viewing images of 
differential valence 
without feedback pre- and 
post-intervention; Heart 
rate (HR) BF (screen color 
HR BF improves HR 
regulation and this 
improvement extends 
to image viewing 
situation (novel 
changes) w/o images emotional context) 
Prinsloo et al. 
(2013) 
Non-clinical adult 
males, work-related 
stress (n=18) 
StressEraser HRV BF vs. 
Control device; modified 
Stroop to induce stress 
BF à large decrease 
in state anxiety; 
Control à moderate 
decrease in state 
anxiety 
Reiner (2008) Anxiety disorder, 
receiving concurrent 
psychotherapy (n=24) 
StressEraser HRV BF, no 
control, pilot; Use as 
adjunct to therapy 
Majority report 
reduced stress, 
increased relaxation 
and positive affect; 
Significant increase in 
effect with increased 
compliance 
Rupert and 
Schroeder (1983) 
Anxiety disorder, 
veterans hospital 
(n=24) 
Heart rate (HR) training + 
BF vs. HR training control 
group vs. adaptation 
(resting) control group 
HR BF did not 
significantly reduce 
HR or anxiety levels, 
but changes in HR 
and anxiety were 
positively related in 
the BF group 
Sherlin et al. 
(2009) 
Non-clinical adults, 
perceived stress 
(n=43) 
StressEraser HRV BF vs. 
Control device 
BF à significantly 
reduced heart rate; 
Non-sig. reduction in 
anxiety 
Wells et al. 
(2012) 
Non-clinical, adult 
musicians (n=46) 
Computer-based HRV BF 
as an intervention for 
induced musical 
performance anxiety vs. 
slow breathing control vs. 
no-intervention control 
Both slow breathing 
and HRV BF 
improved HRV in 
induced-anxiety 
situation; Significant 
reduction in anxiety 
only for high trait-
anxiety individuals for 
both interventions  
Wollburg et al. 
(2011) 
Panic disorder (n=45), 
episodic anxiety 
(n=39), and 
nonanxious controls 
(n=20) 
BF-assisted breathing 
training treatment to raise 
blood carbon dioxide vs. 
BF-assisted breathing 
training treatment to lower 
blood carbon dioxide vs. 
wait-list control; 
Hyperventilation and 
hypoventilation test 
PD – higher baseline 
respiration; Lowering 
therapy à all groups 
lowered carbon 
dioxide, but did not 
effect ventilation test 
performance; Did not 
see differences in PD 
reactivity and 
recovery from 
respiratory challenges 
 
 
 
 
Limitations of Biofeedback Research 
 
There are significant limitations throughout the biofeedback literature reviewed 
here, many of which have already been mentioned. Far too many studies used 
moderate to very small sample sizes, greatly limiting their sensitivity to the 
phenomena of interest. This is especially true in the EMG literature, although 
perhaps it is because the EMG literature mostly features clinical populations that 
may be more difficult to access. Other studies that were able to achieve larger 
sample sizes were in turn limited in the scope of their conclusions because they 
often used non-clinical or mixed-diagnosis populations, such as many of the EEG 
studies. Research has shown that anxiety disorders are often comorbid with other 
mental disorders such as depression, and while a few studies took pains to exclude 
anxious patients with certain other conditions, it is likely that comorbidity limited 
the strength of the results observed. Even when the literature attempted to use a 
clearly diagnosed clinical population, the criteria and even the categorization of 
anxiety disorders changed over time such that it is difficult to compare research on 
DSM-II, DSM-III, DSM-IV and DSM-5 disorders in the event that participants 
may be re-classified across DSM editions. Researchers with long legacies in the 
field are essentially forced to use different terminology and diagnostic criteria 
across time, hindering their ability to draw strong conclusions. 
In addition, many studies did not include a control group. This can be 
explained by ethical concerns to some degree, but other studies utilized the wait 
list control to strengthen their validity. One of the most blatant limitations was the 
inconsistency in biofeedback application (frequency, total time, modality of 
feedback) and existence or latency of follow-up assessment. To truly contribute to 
the biofeedback literature, researchers should determine a standard application of 
each biofeedback technique. With the variable follow-up assessment, it is unclear 
if any improvements seen are sustained or what kind of maintenance might be 
necessary. On the whole, there are severe limitations to the biofeedback research 
reviewed here. 
 
Summary and Conclusions 
 
Implications 
There are certainly many reasons why pharmaceutical treatments for anxiety 
disorders are so popular with patients and clinicians today, but there are significant 
drawbacks that should motivate researchers to develop better treatments. 
Medication alone may seem like an easy solution to a complex disorder, but 
generally has limited efficacy and many side effects. Medication is only a 
treatment as long as the patient is taking the medication; the patient is not learning 
new skills. Medication should be used in conjunction with skill-building therapies 
so that the patient can be weaned off of the drug treatment. It is especially 
important to promote such combined treatment because patients who stand to 
benefit the most from combined or alternative treatment (those with mild 
symptoms) tend to be treated with medication alone (Heinen, 2014). Further, 
individual differences and heterogeneity in presentation of disorders may imply 
that treatments can be tailored to the individual’s particular symptom complex with 
cognitive, behavioral, and physiological symptoms. Therapies with multiple 
components would most likely work in this way, and biofeedback may serve as an 
important component for individuals with somatic or physiological symptoms. 
Overall, further research on biofeedback will contribute to the transition away from 
the disease model of psychopathology with purely pharmaceutical treatment to the 
complex systems learning model in which the individual patient may receive 
unique skill-building therapies targeted to his or her particular needs. 
 
Recommendations for Future Research 
EMG. As EMG research seems to be largely ineffective and inconvenient, I 
do not believe research should continue on EMG as a treatment for anxiety 
disorders. 
EEG. Researchers may continue to study the use of EEG feedback to 
increase alpha wave activity and reduce anxiety symptoms, but it is critical that 
this research be conducted with representative populations and with stringent 
control. A failure of the previous research to show consistent results may be due to 
weak experimental design, and so this research should not be continued unless 
researchers are able to implement a rigorous protocol. The future of EEG research 
seems to be grounded in attentional bias theory, and as such, research should be 
conducted to further investigate the capacity of EEG feedback to alter attentional 
biases of those with clinical anxiety. In particular, the Wang et al. (2013) 
paradigm, previously used to treat Chinese undergraduate students with subclinical 
anxiety, should be replicated with a clinical population to determine if such a 
treatment could benefit individuals with disorder-level anxiety and help treat the 
negative attentional bias of anxiety disorders. 
Additional research is also needed to determine the relative efficacy of 
complementary EEG feedback over cognitive behavioral therapies alone in terms 
of cost-effectiveness, time required to implement, and maintenance of effects over 
time. It is possible that EEG feedback effects, even if strong in the short term, will 
decay over time and individuals may need to regularly visit a trained professional 
for “touch ups.” This possibility should also be considered in studying the 
feasibility of EEG feedback as a treatment for anxiety. 
HRV. HRV feedback seems to be an extremely promising direction for 
developing physiological complementary treatment to traditional therapy. HRV 
feedback is a noninvasive treatment with minimal risk, and HRV is supported by 
research and theory as a measure of autonomic regulation which is central to 
anxiety disorders (Appelhans & Luecken, 2006). Personal HRV feedback monitors 
are affordable and may be a useful addition to traditional psychotherapy as 
therapists often teach anxious patients relaxation techniques and instruct them to 
practice at home, but compliance is mixed. With a personal HRV feedback 
monitor, patients may be more motivated to practice, and at the very least the 
monitors can provide information to the therapist about how much the patient is 
actually practicing so that they can discuss ways to increase compliance (Reiner, 
2008). 
As very few studies on HRV feedback have utilized a clinical population, a 
critical next step for this line of research is to investigate the efficacy of various 
forms of HRV feedback to improve disorder-level anxiety. A large, independent, 
and controlled study of a personal HRV monitor like the StressEraser with a 
clinical population would not only advance understanding of this particular device 
but also help researchers ask more specific questions like which individuals and 
disorders may benefit the most from HRV feedback. Further, heart rate 
biofeedback like that demonstrated in Peira et al. (2013) should also be applied to a 
clinical population to understand how it may help individuals learn anxiety 
management skills that can generalize to daily life outside the therapist’s office. 
 
General recommendations  
Researchers should strive to use stringent methodology utilizing large clinical 
samples with controls to produce informative research that may demonstrate the 
utility of biofeedback in treating anxiety disorders to a satisfactory degree. It is 
important to consider feasibility when developing new biofeedback technology, so 
research should focus on techniques that could easily transfer to a clinical setting. 
Additionally, to compete with the monumental funding of the pharmaceutical 
companies, foundations and other sources of research funding should grant 
financial support to research groups seeking to provide a lower-risk alternative. 
 
Conclusions 
Biofeedback treatments for anxiety disorders are generally promising, especially if 
future research can redress previous methodological limitations. While EMG 
feedback seems to be less effective than other treatments for anxiety, both EEG 
feedback and HRV feedback are potential avenues for impactful and cost-effective 
treatment. Biofeedback therapies may be useful in conjunction with traditional 
psychotherapy for anxiety disorders, as many patients seem open to utilizing 
alternative treatments if they are covered by health insurance (Kessler et al., 2001). 
Further, cost-effective biofeedback may be a beneficial addition to traditional 
school counseling for children as children often experience school-related anxiety 
and may respond particularly well to computer-based interventions which feel like 
games (Matuszek & Rycraft, 2003; Wenck, Leu, & D’Amato, 1996). 
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